Elliott
Coverage of Elliott in the Nexus archive.
- Elliott’s acolytes: how Paul Singer’s hedge fund became a spinout factory
Paul Singer’s hedge fund has generated a small army of new firms, mirroring the 'Tiger cubs' created by Julian Robertson. The article highlights how Elliott has become a factory for spinout hedge funds.
- Elliott Buys Into Braskem’s Debt, Raising the Stakes in Its Rescue
Activist investor Elliott and SVP Global have purchased debt in Braskem, a petrochemical manufacturer, introducing new players into its restructuring process.
- Elliott presses Bunzl for buybacks after building stake
Elliott, a US activist hedge fund, is urging Bunzl, a UK business supplies distributor, to pursue buybacks after acquiring a stake. Bunzl is the latest UK target for Elliott's investment strategy.
- Elliott Is Said to Take Almost 5% Stake in UK Distributor Bunzl
Elliott has acquired nearly a 5% stake in Bunzl Plc, a UK-based distributor.
- Activist Elliott Hits Back at Gold Miner Northern Star Over Sale
Activist Elliott has responded to Northern Star, a gold mining company, regarding a sale. The situation involves a dispute over the sale terms.
- Activist fund Elliott calls for sale of Australia’s largest gold miner
Activist fund Elliott is pushing for the sale of Australia's largest gold miner, Northern Star Resources, as a US firm increases its stake in the company.
- Elliott Takes Stake in Miner Northern Star, Pushing for Review
Elliott has taken a stake in mining company Northern Star and is advocating for a review. The article notes volatility in gold prices amid a stock market selloff and Middle East tensions.
- Synopsys Settles with Elliott, Names Firm’s Jesse Cohn to Board
Synopsys has settled with Elliott and appointed Jesse Cohn to its board. Nvidia Corp. invested $2 billion in Synopsys as part of a collaboration to integrate AI-computing technology into various industries.
- Elliott Builds Stake in Life-Science Firm Bio-Rad, WSJ Says
Elliott is building a stake in Bio-Rad, a life-science firm, according to WSJ. The move indicates Elliott's interest in the life-science industry. Bio-Rad is a leading company in the field.
- Elliott Loses Fight Over $8.7 Billion Buyout of China’s 58.com
Elliott loses fight over $8.7 billion buyout of China's 58.com. The CEO of 58.com is Yao Jinbo. The deal's outcome may impact the future of the company.
- Elliott Said to Tap Banks to Run Barnes & Noble’s London IPO
Barnes & Noble Inc. is planning an initial public offering in London and Elliott is expected to appoint banks to manage the process. The company is the largest retail bookseller in the US with over 600 bookstores.